Shaping the Future of Genomic Innovation

Challenge

Noticing the intense competition in the gene sequencing services market for the healthcare industry, KTest decided to take a different approach by expanding its services to other fields such as agriculture, environmental science, and industry. This strategic move sets them apart from their competitors.

To enhance their capabilities and meet market demands, KTest explored various equipment options from different brands before making key investments in new devices between 2017 and 2023. Despite these investments, KTest remained committed to innovation.

Approach

In 2024, DKSH Technology introduced PacBio’s Onso system, a state-of-the-art system designed to further enhance KTest’s laboratories and keep them at the forefront of technological innovation. Onso is a leading benchtop short-read DNA sequencing platform, powered by PacBio’s ultra-accurate Sequencing by Binding (SBB) technology.

To support KTest in maximizing the system’s potential, we provided a range of value-added services, ensuring the team could efficiently set up and operate the platform with ease and confidence.

Result

PacBio’s Onso system offers exceptional advantages compared to the other brands previously used by KTest. It delivers four times higher performance, enabling faster and more efficient sequencing processes. Additionally, it provides 15 times higher accuracy, ensuring more precise and reliable data for research and industrial applications.

The system also offers greater cost efficiency, allowing KTest to optimize operational expenses while maintaining top-quality results.

By combining Onso’s advanced capabilities with KTest’s deep expertise, this collaboration paves the way for the team to expand their services regionally and globally in the future.